Breadcrumb
NIH Guide: Weekly Index for February 10, 2023
Weekly NIH Funding Opportunities and Notices
February 10, 2023
Policy Notices
-
NIH Encourages the Use of the ARRIVE Essential 10 Checklist in all Publications Reporting on the Results of Vertebrate Animal and Cephalopod Research
(NOT-OD-23-057)Office of the Director, NIH
General Notices
-
Notice of Special Topics of Interest for CDER for PAR-23-072 "FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)"
(NOT-FD-23-007)Food and Drug Administration
-
Notice of NHGRI Participation in the National Science Foundation Molecular Foundations for Biotechnology (MFB) Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology
(NOT-HG-23-020)National Human Genome Research Institute
-
Notice of Technical Assistance Webinar for RFA-HL-24-003 & RFA-HL-24-004 "Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Coordination Center (U24) & (R25 Clinical Trial Not Allowed)"
(NOT-HL-23-075)National Heart, Lung, and Blood Institute
-
Clinical Trials Results Information Submission: Good Cause Extension Request Process and Criteria Document Posted on ClinicalTrials.gov
(NOT-OD-23-080)Office of the Director, NIH
-
Request for Information (RFI): Seeking Input for National Cancer Institute (NCI) Cancer Adoptive Cellular Therapy (Can-ACT) Network on Clinical Trials Data Planning and Sharing
(NOT-CA-23-042)National Cancer Institute
-
Request for Information (RFI): Future Directions in Violence Against Women Research
(NOT-NR-23-008)National Institute of Nursing ResearchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health Disparities
Notice of Changes to Funding Opportunities
-
Notice of Change to Key Dates to RFA-AG-24-003, Interventions Testing Program (ITP) Data Coordinating Center (U24 Clinical Trial Not Allowed)
(NOT-AG-23-003)National Institute on Aging
-
Notice of NCIs Participation in PAR-23-112, Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
(NOT-CA-23-043)National Cancer Institute
-
Notice of Participation of NIMH in PAR-21-169, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)"
(NOT-MH-23-185)National Institute of Mental Health
-
Notice of Participation of NIMH in PAR-21-173, "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
(NOT-MH-23-186)National Institute of Mental Health
-
Notice of Participation of NIMH in PAR-22-080, Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
(NOT-MH-23-190)National Institute of Mental Health
-
Notice of Early Expiration of NINDS BRAIN Initiative Funding Opportunity Announcements (FOA) RFA-NS-21-026 and RFA-NS-21-027
(NOT-NS-23-037)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and Bioengineering
-
Notice of Change to Key Dates for RFA-NS-23-012 "Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)"
(NOT-NS-23-073)National Institute of Neurological Disorders and StrokeOffice of the Director, NIH
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
(NOT-DK-23-012)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
(NOT-NS-23-035)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
(NOT-NS-23-036)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences Research
-
Notice of Intent to Publish a Funding Opportunity Announcement to Reissue RFA-OD-21-002, the Tobacco Regulatory Science (R01 Clinical Trial Optional)
(NOT-OD-23-081)Office of Disease PreventionNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Heart, Lung, and Blood Institute
Requests for Proposal
-
NIA Caenorhabditis Interventions Testing Program (CITP) Announces Annual Call for Compounds to Test for Lifespan Extension in Caenorhabditis
(NOT-AG-23-001)National Institute on Aging
Notices of Special Interest
-
Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes
(NOT-AG-23-004)National Institute on Aging
-
Notice of Special Interest (NOSI): Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals
(NOT-HD-23-003)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
(NOT-MD-23-002)National Institute on Minority Health and Health DisparitiesNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteNational Institute on Drug AbuseNational Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions
(NOT-MD-23-003)National Institute on Minority Health and Health DisparitiesNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteNational Institute on Drug AbuseNational Eye InstituteOffice of Research on Women's Health
-
Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS)
(NOT-NS-23-062)National Institute of Neurological Disorders and Stroke
-
Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
(NOT-OD-23-042)Office of the Director, NIHNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Dental and Craniofacial Research
-
Notice of Special Interest (NOSI): Administrative Supplements to Support the Exploration of Cloud in NIH-supported Research
(NOT-OD-23-070)Office of the Director, NIHNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational Sciences
Funding Opportunities
-
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
(PAR-23-035)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): March 21, 2023
-
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
(PAR-23-090)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): November 6, 2024
-
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
(PAR-23-100)National Institute of General Medical SciencesApplication Receipt Date(s): May 22, 2025
-
Research Coordinating Center on the Exposome and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD): Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed)
(RFA-AG-24-011)National Institute on AgingApplication Receipt Date(s): September 27, 2023
-
Comparative Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation (R01 Clinical Trial Not Allowed)
(RFA-AG-24-019)National Institute on AgingApplication Receipt Date(s): September 27, 2023
-
Networking/Infrastructure Project for Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging Related Outcomes, and Prospects for Translation (R61/R33 Clinical Trial Not Allowed)
(RFA-AG-24-020)National Institute on AgingApplication Receipt Date(s): September 27, 2023
-
Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
(RFA-AI-22-076)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): June 9, 2023
-
Consortium for Food Allergy Research: Leadership Center (UM1 Clinical Trial Required)
(RFA-AI-22-077)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): June 9, 2023
-
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U01 Clinical Trial Not Allowed)
(RFA-AI-23-008)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): June 14, 2023
-
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)
(RFA-DA-24-027)National Institute on Drug AbuseApplication Receipt Date(s): February 8, 2024
-
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
(RFA-DA-24-037)National Institute on Drug AbuseApplication Receipt Date(s): November 15, 2024
-
Limited Competition for the Continuation of the Rare and Atypical Diabetes NeTwork (RADIANT) Specialized Study Centers (U54 - Clinical Trial Not Allowed)
(RFA-DK-22-511)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): June 7, 2023
-
Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
(RFA-DK-23-006)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): May 04, 2023
-
Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required)
(RFA-MD-23-007)National Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Not Applicable
-
Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional)
(RFA-MD-23-008)National Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Not Applicable
-
Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clinical Trial Optional)
(RFA-NS-24-001)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): June 1, 2023
-
Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-OD-23-004)Office of Research on Women's HealthNational Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): January 31, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: January 24, 2025
For technical issues E-mail OER Webmaster